People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
too, like amusement park rides or other situations where sudden changes or extremes of air pressure, altitude or gravity may ...
Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...
Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.
Cross-industry collaboration is key to fighting rising costs for consumers. The Fast Company Impact Council is a private ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...
Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback